Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies-Reference-Cited by-同舟云学术

Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies

Published:2019-05-22 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Kim Victoria M.,Blair Alex B.,Lauer Peter,Foley Kelly,Che Xu,Soares Kevin,Xia Tao,Muth Stephen T.,Kleponis Jennifer,Armstrong Todd D.,Wolfgang Christopher L.,Jaffee Elizabeth M.,Brockstedt Dirk,Zheng Lei^ORCID

Funder

National Institutes of Health

Skip Viragh Foundation

Lefkofsky Family Foundation

National Cancer Institute Specialized Programs of Research Excellence in Gastrointestinal Cancers

Sidney Kimmel Comprehensive Cancer Center

Lustgarten Foundation

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0601-5.pdf

Reference44 articles.

1. Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg. 2013;257(1):17–26.

2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.

3. Compton CC, Mulvihill SJ. Prognostic factors in pancreatic carcinoma. Surg Oncol Clin N Am. 1997;6(3):533–54.

4. Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27(4):450–61.

5. Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161(2):205–14.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations;Current Oncology;2024-08-23

2. Annexin A2: A Double-Edged Sword in Pathogen Infection;Pathogens;2024-07-04

3. Engineered bacteria in tumor immunotherapy;Cancer Letters;2024-05

4. Effect of Annexin A2 on prognosis and sensitivity to immune checkpoint plus tyrosine kinase inhibition in metastatic renal cell carcinoma;Discover Oncology;2024-03-22

5. Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein;Cellular Oncology;2023-11-14